0 Items
Select Page

West Nile Virus

West Nile Virus (WNV) is a cause of neurological disease and death in humans. WNV reached North America in 1999, resulting in a large and dramatic outbreak that continued to spread throughout the USA in the following years. The US WNV outbreak (1999-2010) highlighted the risk posed by importation of vector-borne pathogens outside of their normal range. Since, the virus has spread and is now widely established from Canada to Venezuela.

The Native Antigen Company offers a range of recombinant West Nile virus antigens and highly specific monoclonal antibodies to support research into the infection and assay development.

West Nile Virus Background

West Nile Virus (WNV) is an enveloped, single-stranded RNA virus that belongs to the Flavivirus genus. WNV is a member of the Japanese encephalitis sero-complex, of the family Flaviviridae, which also includes Japanese encephalitis virus, St. Louis encephalitis and Murray Valley encephalitis virus. In nature, West Nile virus is maintained in a cycle between birds and mosquitoes. However, WNV can also be transmitted to incidental hosts such as humans, horses and other mammals by mosquito vectors.

Since the first human WNV infection was identified in 1937, the virus has continued to spread. West Nile virus is now found in many regions of the world including Africa, Europe, West Asia, North and South America. WNV infection is asymptomatic in 80% of cases, but some individuals can develop severe West Nile fever. The symptoms of West Nile fever include fever, headache, nausea and vomiting. The virus has also been associated with neurological complications and fatalities in less than 1% of infected individuals.

Currently, there is no licensed prophylactic vaccine or specific therapeutic treatment for West Nile virus infection in humans. Prevention of WNV infection is through vector control measures and the use of protective clothing to reduce human-to-human transmission.

Reference

  1. Chancey C, et al (2015). The Global Ecology and Epidemiology of West Nile Virus. Biomed Res Int. 376230.

West Nile Virus Antigens

The Native Antigen Company specialises in development and manufacture of native and recombinant viral antigens. Our recombinant antigens are used by pharmaceutical and IVD manufacturers in vaccine research and serology, where proper folding and glycosylation are vital.

We prepare West Nile virus NS1 protein in our proprietary mammalian cell expression system, which generates highly pure NS1 protein in its glycosylated and predominantly hexameric form. Our West Nile virus antigen is ideal for use in immunoassay development and vaccine R&D.

West Nile Virus Antibodies

We have used our recombinant WNV NS1 protein to raise a panel of specific antibodies to WNV NS1 protein, all of which are highly specific and do not cross-react with NS1 proteins from other flaviviruses, including Dengue, Yellow Fever and Japanese Encephalitis viruses

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

We recently teamed-up with Virology Research Services (VRS) who tested a large panel of our viral antibodies in immunofluorescence applications. This work was funded by the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) through the...

Why are ticks such good vectors of pathogens?

In this blog, Professor Patricia Nuttall discusses what makes ticks such effective vectors of pathogens and how we might prevent the spread of tick-borne diseases. About Patrica Nuttall Pat Nuttall is Emeritus Professor of Arbovirology in the Department of Zoology,...

Dengue in 2019

What's going on with dengue? Dengue virus (DENV) has been in the news a lot recently. The number of reported cases continues to climb year-on-year and 2019 has been especially bad. Rio de Janeiro has seen a 45% increase in dengue cases in the first two months of 2019...

Zika Prevalence in Suriname – an insight into assay cross-reactivity

A recent study published by Langerak et al tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...

What should you call your favourite virus?

The International Committee on Taxonomy of Viruses (ICTV) meet regularly to ensure the taxonomy of viruses is kept logical and up-to-date in the face of an ever-increasing number of new viruses and genome sequences; discussed in here in Nature. This sometimes results...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

2 + 15 =

Live Customer Feedback